» Articles » PMID: 36918031

Sudden Death Associated With Possible Flare-Ups of Multiple Sclerosis After COVID-19 Vaccination and Infection: A Case Report and Literature Review

Overview
Specialty General Medicine
Date 2023 Mar 14
PMID 36918031
Authors
Affiliations
Soon will be listed here.
Abstract

We present an autopsy case of a 19-year-old man with a history of epilepsy whose unwitnessed sudden death occurred unexpectedly in the night. About 4 years before death, he was diagnosed with unilateral optic neuritis (ON). Demyelinating disease was suspected, but he was lost to follow up after the recovery. Six months before death, he received a second dose of mRNA coronavirus disease 2019 (COVID-19) vaccine. Three months before death, he experienced epileptic seizures for the first time. Seventeen days before death, he was infected with COVID-19, which showed self-limited course under home isolation. Several days before death, he complained of seizures again at night. Autopsy revealed multifocal gray-tan discoloration in the cerebrum. Histologically, the lesions consisted of active and inactive demyelinated plaques in the perivenous area of the white matter. Perivascular lymphocytic infiltration and microglial cell proliferation were observed in both white matter and cortex. The other major organs including heart and lung were unremarkable. Based on the antemortem history and postmortem findings, the cause of death was determined to be multiple sclerosis with suspected exacerbation. The direct or indirect involvement of cortex and deep gray matter by exacerbated multiple sclerosis may explain the occurrence of seizures. Considering the absence of other structural abnormalities except the inflammatory demyelination of the cerebrum, fatal arrhythmia or laryngospasm in the terminal epileptic seizure may explain his sudden unexpected death in the benign circumstances. In this case, the onset of seizure was preceded by COVID-19 vaccination, and the exacerbation of seizure was preceded by COVID-19 infection, respectively. Literature reporting first manifestation or relapse of multiple sclerosis temporally associated with COVID-19 vaccination or infection are reviewed.

Citing Articles

Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study.

Granja Lopez J, Estebas Armas C, Lorenzo Dieguez M, Puertas Munoz I, de Celis Ruiz E, Rigual R Front Pharmacol. 2024; 15:1376474.

PMID: 39175548 PMC: 11338880. DOI: 10.3389/fphar.2024.1376474.


COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian randomization study.

Shan J, Hu X, Chen T, Wang Y, Huang B, Xin Y Front Public Health. 2024; 12:1322140.

PMID: 38550316 PMC: 10973840. DOI: 10.3389/fpubh.2024.1322140.


Sudden Death Is More Likely to Result From SARS-COV-2 Infection Than Multiple Sclerosis.

Finsterer J J Korean Med Sci. 2023; 38(44):e393.

PMID: 37967883 PMC: 10643249. DOI: 10.3346/jkms.2023.38.e393.

References
1.
Karsidag S, Sahin S, Ates M, Cinar N, Kendirli S . Demyelinating Disease of the Central Nervous System Concurrent With COVID-19. Cureus. 2021; 13(8):e17297. PMC: 8449512. DOI: 10.7759/cureus.17297. View

2.
Popescu B, Pirko I, Lucchinetti C . Pathology of multiple sclerosis: where do we stand?. Continuum (Minneap Minn). 2013; 19(4 Multiple Sclerosis):901-21. PMC: 3915566. DOI: 10.1212/01.CON.0000433291.23091.65. View

3.
Wilejto M, Shroff M, Buncic J, Kennedy J, Goia C, Banwell B . The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology. 2006; 67(2):258-62. DOI: 10.1212/01.wnl.0000224757.69746.fb. View

4.
Sarwar S, Rogers S, Mohamed A, Ogula E, Ayantayo R, Ahmed A . Multiple Sclerosis Following SARS-CoV-2 Infection: A Case Report and Literature Review. Cureus. 2021; 13(10):e19036. PMC: 8612412. DOI: 10.7759/cureus.19036. View

5.
Nistri R, Barbuti E, Rinaldi V, Tufano L, Pozzilli V, Ianniello A . Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases. Front Neurol. 2021; 12:765954. PMC: 8569136. DOI: 10.3389/fneur.2021.765954. View